High-dosage betahistine dihydrochloride between 288 and 480 mg/day in patients with severe Menière's disease: A case series

European Archives of Oto-Rhino-Laryngology

Volumn 268, Issue 8, 2011, Pages 1237-1240

  Lezius, Franziska ^a   Adrion, Christine ^a   Mansmann, Ulrich ^a   Jahn, Klaus ^a   Strupp, Michael ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Attacks of vertigo; Betahistine dihydrochloride; High dosage treatment; Meni re's disease

Indexed keywords

BETAHISTINE; GAMMA GLUTAMYLTRANSFERASE;

ADULT; AGED; ARTICLE; CASE STUDY; CLINICAL ARTICLE; DISEASE SEVERITY; DRUG EFFICACY; DRUG MEGADOSE; DRUG RESPONSE; DRUG TOLERABILITY; FATIGUE; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GASTROINTESTINAL SYMPTOM; HUMAN; MALE; MENIERE DISEASE; PATIENT MONITORING; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SIDE EFFECT; TASTE DISORDER; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; AGED; AGED, 80 AND OVER; BETAHISTINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MENIERE DISEASE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 79960204109     PISSN: 09374477     EISSN: 14344726     Source Type: Journal    
DOI: 10.1007/s00405-011-1647-2     Document Type: Article

References (11)

1. Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Meniere's disease. American Academy of Otolaryngology-Head and Neck Foundation, Inc. Otolaryngol Head Neck Surg. (1995) 113(3):181-185
2. SN Merchant JC Adams JB Nadol Jr 2005 Pathophysiology of Meniere's syndrome: are symptoms caused by endolymphatic hydrops? Otol Neurotol 26 1 74 81 15699723 10.1097/00129492-200501000-00013 (Pubitemid 40130213)
3. M Dieterich T Brandt 1999 Episodic vertigo related to migraine (90 cases): vestibular migraine? J Neurol 246 10 883 892 10552234 10.1007/s004150050478 1:STN:280:DC%2BD3c%2FitVentw%3D%3D (Pubitemid 29512157)
4. JM Guilemany P Martinez E Prades I Sanudo R De Espana A Cuchi 2004 Clinical and epidemiological study of vertigo at an outpatient clinic Acta Otolaryngol 124 1 49 52 14977078 10.1080/00016480310002122 1:STN:280: DC%2BD2c%2FoslCksw%3D%3D (Pubitemid 38177851)
5. H Neuhauser M Leopold M von Brevern G Arnold T Lempert 2001 The interrelations of migraine, vertigo, and migrainous vertigo Neurology 56 4 436 441 11222783 1:STN:280:DC%2BD3M7ps1Kiug%3D%3D (Pubitemid 32172864)
6. N van Cruijsen JP Jaspers HB van de Wiel HP Wit FW Albers 2006 Psychological assessment of patients with Meniere's disease Int J Audiol 45 9 496 502 17005492 10.1080/14992020600753239 (Pubitemid 44483980)
7. A Eckhardt-Henn C Best S Bense P Breuer G Diener R Tschan, et al. 2008 Psychiatric comorbidity in different organic vertigo syndromes J Neurol 255 3 420 428 18338198 10.1007/s00415-008-0697-x
8. H Sajjadi MM Paparella 2008 Meniere's disease Lancet 372 9636 406 414 18675691 10.1016/S0140-6736(08)61161-7
9. M Strupp D Hupert C Frenzel J Wagner A Hahn K Jahn, et al. 2008 Long-term prophylactic treatment of attacks of vertigo in Meniere's disease-comparison of a high with a low dosage of betahistine in an open trial Acta Otolaryngol 128 5 520 524 18421605 10.1080/00016480701724912 1:CAS:528:DC%2BD1cXkvFOltbs%3D (Pubitemid 351550965)
10. S Jeck-Thole W Wagner 2006 Betahistine: a retrospective synopsis of safety data Drug Saf 29 11 1049 1059 17061910 10.2165/00002018-200629110-00004 1:CAS:528:DC%2BD28XhtlensrfE (Pubitemid 44912713)
11. James AL, Burton MJ (2001) Betahistine for Meniere's disease or syndrome. Cochrane Database Syst Rev (1): CD001873